The “New Drug Discovery in China” conference will provide a forum for R&D leaders of major Chinese and American pharmaceutical companies to share their successes and challenges in drug discovery. This event will be a valuable opportunity for learning amongst professionals, academicians and students in the Midwest area of USA. This conference will also serve as a platform to foster the interactions and communications among pharmaceutical professionals from Chicago, Indianapolis, Cincinnati, Columbus and other cities in the vicinity. As globalization of pharmaceutical industry continues, R&D is gaining momentum in emerging markets such as China. Better insight of new drug discovery in China is highly important to US pharma companies for their market strategy and potential collaborations. This conference will aim at providing an update on the scope and status of drug development in China, as well as a juncture for US-based professionals to find career development opportunities in both US and China.
Agenda
Morning Session 1: Moderator: Wanqing Liu, Ph.D, Assistant Professor, Purdue University
9:00 AM— 9:10 PM Opening Remark Harry Zhang, Ph.D, PharmD, President, SAPA-Midwest
Zhenge Zhao, China Council for the Promotion of International Trade, Head of China Delegation for Bio 2013
9:10 AM—9:20 AM Introduction to SAPA
Mingde Xia, Ph.D, Ex-President, SAPA
9:20 AM—9:30 AM Introduction to YAO YUAN—Academy for Pharma Innovation
Gui-Dong Zhu, Ph.D, President, Yao Yuan—Academy for Pharma Innovation
9:30 AM—9:40 AM Greetings from Consulate General of People’s Republic of China in Chicago
Ming Chen, Counselor for Science & Technology
9:40 AM—10:10 AM Biosimilars: Making Expensive Biologics Accessible to Patients Worldwide
David Shen, Ph.D, Vice President, Global Head of Biologics Development, Head of Teva-Lonza Joint Venture, Teva Pharmaceutical
10:10 AM—10:40 AM Status and Prospects of Chinese Bio-pharmaceutical Industry
Shaoxiong Chen, Executive President, Shanghai Biopharmaceutics Industry Association
10:40 PM—11:00 PM Break
Morning Session 2: Moderator: Feng Fang, Ph.D, Vice President, SAPA Midwest; Yupeng (David) He, Ph.D, Vice President, SAPA Midwest
11:00 AM—11:30 AM Open Innovation in the Diversified Healthcare Industry
Mingde Xia, Ph.D, Sr. Director, Johnson & Johnson Innovation Center, Shanghai
11:30 AM—12:00 AM From Imitation to Innovation: Hengrui’s Journey
Mike Liu, Head of Global Business Development, Jiangsu Hengrui Medicine
12:00 AM—1:00 PM Lunch
After Lunch Session: Moderator: Hongwei Wang, Ph.D, Research Assistant Professor, the University of Chicago
1:00 PM—1:20 PM The Important Role of a CRO in New Drug Discovery in China.
Chen Chen, CEO, Sundia MediTech Company, Ltd.
1:20 PM—1:40 PM Wuhan Biolake, the emerging life science cluster in China
Zhe Li, CEO of Wuhan Optics Valley Biomedical Industrial Park
1:40 PM—2:00 PM World Patent Database of Traditional Medicine in Drug Innovation
Yanhuai Liu, Chairman, Beijing Eastlinden Science&Technology CO.,LTD
2:00 PM— 2:20 PM Current Development Plan and Future Perspective at Jinan Pharma Incubator
Ke Wang, Manager of Business Development, Jinan High-tech Business Incubator
2:20 PM—2:50 PM Coffee Break
Afternoon Session : Moderator: Alex Ye, Ph.D., Director of Business Development, Laureate Biophar- maceutical Services, Inc.
2:50 PM—3:20 PM Strategies for Developing Biosimilars and Biobetters
Michiel Ultee, Ph.D, CSO, Laureate Biopharmaceutical Services, Inc.
3:20 PM—3:50 PM My Experience of Biotech Start-up In China
John Yu, CEO of CGeneTech Suzhou
3:50 PM Conclusion
Organizing Committee of “New Drug Discovery in China 2013” Conference
SAPA Midwest: Harry Zhang (Co-chair), Feng Fang, Yupeng (David) He, Steve Yu, Hong-Bo Lin, Xiaohong Yu, Quanbo Xiong, Jiquan Gao
YAO YUAN—Academy for Pharma Innovation: Hongwei Wang (Co-chair), Wangqing Liu, Xiangdong Xu, Liangjun Lu, Hongyu Zhao, Zhifu Tao, Shawn Chen, Paul Mar, Gui-Dong Zhu
Acknowledgment
Wei Ding, Jiwen Chen, Handan He, Xiaotian Zhong, Tingjing Hu, Sean Zhang, Weiguo Dai, Boping Ye, Dong Cheng, Hong Zhao, Xiaoying Liu, Xingchun Zhou, Wen Hong
Sponsors
SPV Jiaxing International Bio-Tech Park , Nanjing Sanhome Pharmaceutical Co.,LTD, Wuhan Optics Valley Biomedical Industrial Park , Jinan High-tech Business Incubator, Beijing Eastlinden Science&Technology CO.,LTD, Laureate Biopharmaceutical Services, Inc, Sundia MediTech Company, Ltd.